*Some Market data delayed by 15 mins.

Verve Therapeutics, Inc. Common Stock

Symbol: VERV (NASDAQ)
6.78 ▲ (6.36%) 0.405

Company Description:
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

Key Stats
  • Today's Open: $6.48
  • Today's High: $7.13
  • Today's Low: $6.345
  • Today's Volume: 1.40M
  • Yesterday Close: $6.37
  • Yesterday High: $6.69
  • Yesterday Low: $6.3
  • Yesterday Volume: 1.52M
  • Last Min Volume: 500
  • Last Min High: $6.775
  • Last Min Low: $6.775
  • Last Min VWAP: $6.775
Company Profile
  • Name: Verve Therapeutics, Inc. Common Stock
  • Website: https://www.vervetx.com
  • Listed Date: 2021-06-17
  • Location: BOSTON, MA
  • Market Status: Active
  • CIK Number: 0001840574
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $565.09M
  • Round Lot: 100
  • Outstanding Shares: 83.97M
  • Asset Type: CS
RECENT FILINGS FOR VERV
Filing DateFiling TypeFormat
2024-07-024View
2024-06-288-KView
2024-06-284View
2024-06-284View
2024-06-284View
2024-06-284View
2024-06-284View
2024-06-284View
2024-06-284View
2024-06-284View
2024-06-288-K/AView
2024-06-283View
2024-06-283View
2024-06-283View
2024-06-27SC 13GView
2024-06-254View
2024-06-253View
2024-06-078-KView
2024-05-318-KView
2024-05-154View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.